In this episode I talk about Staphylococcus aureus. This is one of the most common organisms seen in Clinical Microbiology and a very serious one. Tune in to find about more about this organism, including...

Melinta Therapeutics, LLC (Melinta), today announced that the U.S. Food and Drug Administration (FDA) has approved KIMYRSA™ (oritavancin)  for the treatment of adult patients with acute bacterial skin...

For Michigan State University’s Felicia Wu, the surprise isn’t that people who work with livestock are at higher risk of picking up antibiotic-resistant bacteria, but instead how much higher their...

Staph bacteria, the leading cause of potentially dangerous skin infections, are most feared for the drug-resistant strains that have become a serious threat to public health. Attempts to develop a vaccine...

By: Andrea M. Bagley RN, BSN, CEN Although rare, zoonotic diseases such as Methicillin –resistant Staphylococcus aureus (MRSA) have been shown to be transmitted from humans to horses and horses to humans...

New multicenter research, which included Vanderbilt University Medical Center investigators, could change treatment approaches to simple skin abscesses, infections often caused by Staphylococcus aureus (staph)...

Telephus Medical LLC (Telephus), a biotechnology company focused on development of antibody therapies for antibiotic-resistant staphylococcal infections, announced that the Japan Patent Office has issued...

Following a plethora of reports one week ago concerning possible adverse events due to vaccines that killed two children in Chiapas, Mexico, the results of an investigation performed by the Mexican Institute...